Blood pressure and renal function before and after percutaneous transluminal renal angioplasty in fibromuscular dysplasia: A cohort study

Jasper V. Smit, Thomas K. A. Wierema, Abraham A. Kroon, Peter W. de Leeuw*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Objective: To evaluate the long-term effects of percutaneous transluminal renal angioplasty (PTRA) on blood pressure and renal function in patients with fibromuscular dysplasia (FMD). Methods: Patients in whom FMD was diagnosed during renal angiography (n = 51) were compared with a matched group of hypertensive patients in whom angiography revealed normal renal arteries (n = 51). Blood pressure, intensity of antihypertensive medication and creatinine clearance were assessed at 0, 1, 6 and 12 months. In addition, we recorded the frequencies of cure, improvement and failure of treatment. Results: The two groups did not differ with regard to baseline characteristics. In the FMD group, average blood pressure fell from 172/97 to 155/90mmHg (P
Original languageEnglish
Pages (from-to)1183-1188
JournalJournal of Hypertension
Volume31
Issue number6
DOIs
Publication statusPublished - Jun 2013

Keywords

  • cohort studies
  • fibromuscular dysplasia
  • hypertension
  • percutaneous transluminal angioplasty
  • renal artery stenosis
  • revascularization

Cite this